Pamplona, Spain

Daniel Ajona Martínez-Polo

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Ajona Martínez-Polo

Introduction

Daniel Ajona Martínez-Polo is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer. His innovative approach has the potential to improve the accuracy of lung cancer diagnosis and prognosis.

Latest Patents

Daniel Ajona Martínez-Polo holds a patent for a method of diagnosing and/or prognosing lung cancer. This invention involves determining the level of a C4 activation fragment in a test sample and comparing it with a control sample. If the level of the C4 activation fragment is higher than that in the reference control, it indicates that the subject may suffer from lung cancer or have a poor prognosis. This method not only aids in diagnosis but also helps in assessing the risk of developing lung cancer and evaluating the efficacy of medical regimens. His patent is a significant advancement in the field, providing high sensitivity and specificity in lung cancer detection.

Career Highlights

Throughout his career, Daniel has worked with various organizations that focus on biomedical research. Notable among these are Proyecto de Biomedicina Cima, S.L. and Fundación para la Investigación Médica Aplicada. His work in these institutions has allowed him to contribute to groundbreaking research and innovations in medical science.

Collaborations

Daniel has collaborated with esteemed colleagues such as Leticia Corrales Pecino and Luis Montuenga Badía. These partnerships have fostered a collaborative environment that enhances research and innovation in the medical field.

Conclusion

Daniel Ajona Martínez-Polo's contributions to lung cancer diagnostics exemplify the impact of innovative thinking in medicine. His patent for a method involving C4 activation fragments represents a significant step forward in the fight against lung cancer. His work continues to inspire advancements in medical research and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…